GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity

References

• Abele AE, Scholz KP, Scholz WK, Miller RJ (1990). Excitotoxicity induced by enhanced excitatory neurotransmission in cultured hippocampal pyramidal neurons. Neuron 4:413–419.
   Google Scholar
• Berger UV, Luthi-Carter R, Passani LA, Elkabes S, Black I, Konradi C, Coyle JT (1999). Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J Comp Neurol 415:52–64.
   Google Scholar
• Bodner A, Maroney AC, Finn JP, Ghadge G, Roos R, Miller RJ (2002). Mixed lineage kinase 3 mediates gp120IIIB-induced neurotoxicity. J Neurochem 82:1424–1434.
   Google Scholar
• Bruno V, Battaglia G, Casabona G, Copani A, Caciagli F, Nicoletti F (1998a). Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J Neurosci 18:9594–9600.
   PubMed Web of Science ®Google Scholar
• Bruno V, Sureda FX, Storto M, Casabona G, Caruso A, Knopfel T, Kuhn R, Nicoletti F (1997). The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling. J Neurosci 17:1891–1897.
   Google Scholar
• Bruno V, Wroblewska B, Wroblewski JT, Fiore L, Nicoletti F (1998b). Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells. Neuroscience 85:751–757.
   PubMed Web of Science ®Google Scholar
• Buisson A, Choi DW (1995). The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death. Neuropharmacology 34:1081–1087.
   PubMedGoogle Scholar
• Cassidy M, Neale JH (1993). N-acetylaspartylglutamate catabolism is achieved by an enzyme on the cell surface of neurons and glia. Neuropeptides 24:271–278.
   Google Scholar
• Ferraguti F, Baldani-Guerra B, Corsi M, Nakanishi S, Corti C (1999). Activation of the extracellular signal-regulated kinase 2 by metabotropic glutamate receptors. Eur J Neurosci 11:2073–2082.
   PubMedGoogle Scholar
• Flanders KC, Ren RF, Lippa CF (1998). Transforming growth factor-betas in neurodegenerative disease. Prog Neurobiol 54:71–85.
   PubMed Web of Science ®Google Scholar
• Genazzani AA, L'Episcopo MR, Casabona G, Shinozaki H, Nicoletti F (1994). (2S,1′R,2′R,3′R)-2-(2,3-dicarboxycyclopropyl) glycine positively modulates metabotropic glutamate receptors coupled to polyphosphoinositide hydrolysis in rat hippocampal slices. Brain Res 659:10–16.
   Google Scholar
• Jackson PF, Cole DC, Slusher BS, Stetz SL, Ross LE, Donzanti BA, Trainor DA (1996). Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase. J Med Chem 39:619–22.
   PubMed Web of Science ®Google Scholar
• Kaul M, Garden GA, Lipton SA (2001). Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988–994.
   PubMed Web of Science ®Google Scholar
• Lipton SA (1994). HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists. Mol Neurobiol 8:181–196.
   Google Scholar
• Lipton SA (1998). Neuronal injury associated with HIV-1: approaches to treatment. Annu Rev Pharmacol Toxicol 38:159–177.
   PubMed Web of Science ®Google Scholar
• Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB (1991). Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7:111–118.
   PubMed Web of Science ®Google Scholar
• Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ (1998). Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci U S A 95:14500–14505.
   PubMed Web of Science ®Google Scholar
• Meucci O, Miller RJ (1996). gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1. J Neurosci 16:4080–4088.
   Web of Science ®Google Scholar
• Neale JH, Olszewski RT, Gehl LM, Wroblewska B, Bzdega T (2005). The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia. Trends Pharmacol Sci 26:477–84.
   PubMed Web of Science ®Google Scholar
• Pin JP, Duvoisin R (1995). The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34:1–26.
   PubMed Web of Science ®Google Scholar
• Robinson MB, Blakely RD, Couto R, Coyle JT (1987). Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. J Biol Chem 262:14498–14506.
   PubMed Web of Science ®Google Scholar
• Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001). HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology 56:257–260.
   PubMed Web of Science ®Google Scholar
• Sanchez-Prieto J, Budd DC, Herrero I, Vazquez E, Nicholls DG (1996). Presynaptic receptors and the control of glutamate exocytosis. Trends Neurosci 19:235–239.
   Google Scholar
• Sindou P, Couratier P, Esclaire F, Yardin C, Bousseau A, Hugon J (1994). Prevention of HIV coat protein (gp120) toxicity in cortical cell cultures by riluzole. J Neurol Sci 126:133-137.
   Google Scholar
• Slusher BS, Vornov JJ, Thomas AG, Hurn PD, Harukuni I, Bhardwaj A, Traystman RJ, Robinson MB, Britton P, Lu XC, Tortella FC, Wozniak KM, Yudkoff M, Potter BM, Jackson PF (1999). Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat Med 5:1396–1402.
   PubMed Web of Science ®Google Scholar
• Stauch BL, Robinson MB, Forloni G, Tsai G, Coyle JT (1989). The effects of N-acetylated alpha-linked acidic dipeptidase (NAALADase) inhibitors on [3H]NAAG catabolism in vivo. Neurosci Lett 100:295–300.
   Google Scholar
• Thomas AG, Liu W, Olkowski JL, Tang Z, Lin Q, Lu XC, Slusher BS (2001). Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta. Eur J Pharmacol 430:33–40.
   PubMed Web of Science ®Google Scholar
• Thomas AG, Vornov JJ, Olkowski JL, Merion AT, Slusher BS (2000). N-Acetylated alpha-linked acidic dipeptidase converts N-acetylaspartylglutamate from a neuroprotectant to a neurotoxin. J Pharmacol Exp Ther 295:16–22.
   PubMedGoogle Scholar
• Tortella FC, Lin Y, Ved H, Slusher BS, Dave JR (2000). Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons. Eur J Pharmacol 402:31–37.
   PubMedGoogle Scholar
• Vesce S, Bezzi P, Rossi D, Meldolesi J, Volterra A (1997). HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid. FEBS Lett 411:107–109.
   PubMed Web of Science ®Google Scholar
• Winder DG, Conn PJ (1993). Activation of metabotropic glutamate receptors increases cAMP accumulation in hippocampus by potentiating responses to endogenous adenosine. J Neurosci 13:38–44.
   Google Scholar
• Wroblewska B, Wroblewski JT, Pshenichkin S, Surin A, Sullivan SE, Neale JH (1997). N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J Neurochem 69:174–18.
   PubMed Web of Science ®Google Scholar